beware medadvisors speculators, page-6

Bottom of this LiveWire article a mention of MDR

https://www.livewiremarkets.com/wires/strategic-deals-at-premiums-but-no-one-cares

"Back in October 2017, medication management tech company MedAdvisor (ASX code: MDR) raised $9.5m by placing shares to pharmaceutical distribution group EBOS (ASX code: EBO) at a price of $0.0575 a share, which was trading at $0.036 a share ahead of that deal. Despite some initial market optimism on the back of the deal, for most of calendar 2018 MDR has traded well below the price EBO agreed to pay and, in recent months, below the pre-EBO market price. Equitable Investors has been opportunistically adding to its holding".